ADAM, Zdeněk, M. KRAHULOVÁ, S. ŠPELDA, Jiří VORLÍČEK, N. HEJLOVÁ, Roman HÁJEK and Miroslav TOMÍŠKA. Therapy of anemia in patients with multiple myeloma. Acta medica Austriaca. Austria: Springer Verlag, 1995, vol. 22, No 4, p. 59-64. ISSN 0303-8173.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Therapy of anemia in patients with multiple myeloma
Name in Czech Léčba anémie u pacientů s mnohočetným myelomem
Authors ADAM, Zdeněk (203 Czech Republic, guarantor), M. KRAHULOVÁ (203 Czech Republic), S. ŠPELDA (203 Czech Republic), Jiří VORLÍČEK (203 Czech Republic), N. HEJLOVÁ (203 Czech Republic), Roman HÁJEK (203 Czech Republic) and Miroslav TOMÍŠKA (203 Czech Republic).
Edition Acta medica Austriaca, Austria, Springer Verlag, 1995, 0303-8173.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Austria
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
UT WoS A1995UA60200001
Keywords (in Czech) mnohočetný myelom; anémie
Keywords in English multiple myeloma;anemia
Tags anemia, multiple myeloma
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 24/6/2009 10:30.
Abstract
Multiple myeloma is very frequently associated with anemia which has the character of hypoproliferative anemia of chronic diseases. In this type of anemia there is often insufficient production of endogenous erythropoietin. According to literature pharmacological doses of erythropoietin result in the increase of blood hemoglobin concentration. Erythropoietin (Eprex Cilag) was given to 11 patients whose hemoglobin concentration in blood was lower than 100 g/l.
Abstract (in Czech)
V článku je popisována léčba anemií u pacientů s mnohočetným myelomem.
PrintDisplayed: 28/8/2024 14:44